Literature DB >> 25446850

Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2α biosynthesis and action in ovarian endometriosis tissue and in model cell lines.

Maša Sinreih1, Maja Anko1, Neli Hevir Kene1, Vida Kocbek1, Tea Lanišnik Rižner2.   

Abstract

Endometriosis is a frequent benign gynecological disease characterized by endometrial tissue outside the uterine cavity. The estimated prevalence in the general population is 6-10%, but this reaches 30-50% in women with infertility and/or pain. As ectopic tissue within the pelvic cavity provokes inflammation, endometriosis is also considered a chronic inflammatory disease, and is characterized by increased peritoneal fluid levels of prostaglandin (PG)E2 and PGF2α. The AKR1B1 and AKR1C3 enzymes act as PG synthases and catalyze reduction of PGH2 to PGF2α, and PGD2 to 9α,11β-PGF2α, respectively. AKR1B1 and AKR1C3 may thus be associated with increased PGF2α production in endometriosis patients, as supported by our previous report of increased AKR1C1-AKR1C3 mRNA levels in endometriotic tissue, compared to control endometrium. Here, we initially evaluated PGF2α concentrations in peritoneal fluid from endometriosis patients and healthy women. We also examined expression of AKR1B1, AKR1C3 and other genes involved in PGF2α biosynthesis, metabolism, and action in ovarian endometriosis tissue versus healthy endometrium, and in peritoneal endometriosis and control endometrium model cell lines. Compared to controls, increased PGF2α concentrations in peritoneal fluid of patients were supported by endometriotic tissue showing increased AKR1B1 mRNA and protein levels, but unchanged AKR1C3 protein levels. Among genes involved in PGF2α biosynthesis, metabolism and action PLA2G2A, PTGS2/COX-2, ABCC4 and PTGFR were up-regulated, mRNA levels of SLCO2A, PTGDS and HPGDS were unchanged, and genes PLA2G4A and HPGD were down-regulated in diseased tissue. All of these PGF2α-associated genes were also expressed in control endometrial HIEEC epithelial and HIESC stromal cell lines, and in peritoneal endometriosis 12-Z epithelial and 22-B stromal cell lines. Higher expression of PLA2G2A, PTGS2, AKR1B1, AKR1C3 and ABCC4 was seen in 22-B endometriosis cells compared to HIESC control cells. These cell models characterized in this study will enable further investigations into the role of PGF2α in the pathophysiology of endometriosis and the involvement of AKR1B1 and AKR1C3.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Inflammation; Phospholipase A2; Prostaglandin synthase; Prostaglandins

Mesh:

Substances:

Year:  2014        PMID: 25446850     DOI: 10.1016/j.cbi.2014.11.009

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  9 in total

Review 1.  AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders.

Authors:  Trevor M Penning
Journal:  Mol Cell Endocrinol       Date:  2018-09-19       Impact factor: 4.102

2.  Single cell transcriptomic analysis identifies novel vascular smooth muscle subsets under high hydrostatic pressure.

Authors:  Zhenzhen Chen; Haizeng Zhang; Yingnan Bai; Changting Cui; Shuangyue Li; Wenjie Wang; Yue Deng; Qiannan Gao; Lu Wang; Wei Qi; Lijun Zhang; Yan Yang; Bin Geng; Jun Cai
Journal:  Sci China Life Sci       Date:  2021-01-21       Impact factor: 6.038

3.  Identification of novel epithelial ovarian cancer loci in women of African ancestry.

Authors:  Ani Manichaikul; Lauren C Peres; Xin-Qun Wang; Mollie E Barnard; Deanna Chyn; Xin Sheng; Zhaohui Du; Jonathan Tyrer; Joseph Dennis; Ann G Schwartz; Michele L Cote; Edward Peters; Patricia G Moorman; Melissa Bondy; Jill S Barnholtz-Sloan; Paul Terry; Anthony J Alberg; Elisa V Bandera; Ellen Funkhouser; Anna H Wu; Celeste Leigh Pearce; Malcom Pike; Veronica Wendy Setiawan; Christopher A Haiman; Julie R Palmer; Loic LeMarchand; Lynne R Wilkens; Andrew Berchuck; Jennifer A Doherty; Francesmary Modugno; Roberta Ness; Kirsten Moysich; Beth Y Karlan; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Kate Lawrenson; Simon Gayther; Thomas A Sellers; Paul Pharoah; Joellen M Schildkraut
Journal:  Int J Cancer       Date:  2019-10-08       Impact factor: 7.316

Review 4.  Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy.

Authors:  Chen-Ming Zeng; Lin-Lin Chang; Mei-Dan Ying; Ji Cao; Qiao-Jun He; Hong Zhu; Bo Yang
Journal:  Front Pharmacol       Date:  2017-03-14       Impact factor: 5.810

5.  Effects of trans-(±)-kusunokinin on chemosensitive and chemoresistant ovarian cancer cells.

Authors:  Nadeeya Mad-Adam; Thidarath Rattanaburee; Tanotnon Tanawattanasuntorn; Potchanapond Graidist
Journal:  Oncol Lett       Date:  2021-12-22       Impact factor: 2.967

6.  Effectiveness of Gamma Oryzanol on prevention of surgical induced endometriosis development in rat model.

Authors:  Mohammad Yari Eisalou; Mohammad Reza Farahpour
Journal:  Sci Rep       Date:  2022-02-18       Impact factor: 4.379

7.  Bioinformatics Analysis and Structure of Gastric Cancer Prognosis Model Based on Lipid Metabolism and Immune Microenvironment.

Authors:  Yongzhi Chen; Hongjun Yuan; Qian Yu; Jianyu Pang; Miaomiao Sheng; Wenru Tang
Journal:  Genes (Basel)       Date:  2022-09-03       Impact factor: 4.141

8.  Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism.

Authors:  Antonio Mercorio; Pierluigi Giampaolino; Andrea Romano; Patrick Dällenbach; Nicola Pluchino
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

9.  Genome-wide association study identifies candidate loci associated with chronic pain and postherpetic neuralgia.

Authors:  Daisuke Nishizawa; Masako Iseki; Hideko Arita; Kazuo Hanaoka; Choku Yajima; Jitsu Kato; Setsuro Ogawa; Ayako Hiranuma; Shinya Kasai; Junko Hasegawa; Masakazu Hayashida; Kazutaka Ikeda
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.